HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: AZD2171 Patient Characteristics

Read the patient characteristics in a current clinical trial being conducted to study the effects of AZD2171 for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Patient Characteristics: • ECOG performance status (PS) 0-1 OR Karnofsky PS 70-100% • Life expectancy > 3 months • WBC = 3,000/mm³ • Absolute neutrophil count = 1,500/mm³ • Hemoglobin = 8 g/dL • Platelets = 100,000/mm³ • Total bilirubin normal • AST/ALT = 2.5 times upper limit of normal (ULN) • Creatinine normal OR creatinine clearance > 60 mL/min • Fertile patients must use effective contraception • Not pregnant or nursing • Negative pregnancy test • No history of allergic reactions to compounds of similar chemical or biologic composition to AZD2171 • Mean QTc = 500 msec (with Bazett's correction) by EKG • No history of long QT syndrome • Proteinuria = 1+ on two consecutive dipsticks taken = 1 week apart • No other concurrent malignancy • No New York Heart Association class III or IV cardiac disease

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
AZD2171 trial for mesothelioma patients
AZD2171 trial for mesothelioma disease
Mesothelioma patient study of AZD2171 effects
AZD2171 therapy for mesothelioma patients
Contact info for mesothelioma AZD2171 facilities


RETURN BACK TO
Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

AZD2171 therapy for mesothelioma patients Therapy program to treat mesothelioma patients with AZD2171
Read about AZD2171 therapy trial with mesothelioma patients

AZD2171 trial for mesothelioma disease Clinical trial to treat mesothelioma disease with AZD2171 therapy
Disease characteristics in mesothelioma patients treated with AZD2171

AZD2171 therapy for mesothelioma patients Clinical trial of AZD2171 therapy for mesothelioma patients
AZD2171 may inhibit cancer cell growth in mesothelioma patients